Market Cap: $940.17M
QC
QuidelOrtho Corporation
QDEL
NASDAQ (NASDAQ Global Select)USD
Market Cap: $940.17M
QuidelOrtho Corporation (Ticker: QDEL) strengthens its leadership team with the appointment of Micah Young as the new Chief Financial Officer, effective July 6, 2026. Young takes over from Joseph M. B…
QuidelOrtho, a leader in diagnostic innovation (Ticker: QDEL), announces a partnership with the Allo Hope Foundation to enhance prenatal care for families facing maternal alloimmunization. This collab…
QuidelOrtho Strengthens Legal Leadership with New Appointment QuidelOrtho Corporation has made a significant move to enhance its executive team by appointing Nathaniel "Nate" Sisitsky as the new Chief…
QuidelOrtho wins EMEA service certification Certified service design signals industry pivot QuidelOrtho is the first medical device company to receive the Excellence Services Label from Esprit de Serv…
Innovative Diagnostics: QuidelOrtho's Commitment to Transforming Patient Care QuidelOrtho Corporation, a prominent player in the in vitro diagnostics arena, showcases its dedication to advancing healt…
### QuidelOrtho Enhances Diagnostic Capabilities with New Product Launch QuidelOrtho, a leader in rapid diagnostic testing, announces the launch of its latest product aimed at improving the speed and…
QuidelOrtho's Strategic Growth Amid Industry Challenges QuidelOrtho is positioned at the forefront of the diagnostics industry, showcasing a commitment to innovation and market expansion that is incre…
QuidelOrtho Navigates the Landscape of Diagnostic Innovations Amid Industry Challenges QuidelOrtho, a leader in the diagnostics industry, is witnessing a dynamic landscape as it continues to innovate…
Unlocking the Future of Diagnostics: The Role of Informatics in Clinical Decision-Making QuidelOrtho Corporation, a leading player in the in vitro diagnostics sector, continues to advance healthcare t…
QuidelOrtho Reinforces Leadership in Transfusion Medicine at AABB 2025 Annual Meeting QuidelOrtho Corporation, a key player in the in vitro diagnostics sector, showcases its commitment to advancing tr…
QuidelOrtho Advances Community Health Through Innovative Diagnostic Solutions QuidelOrtho Corporation, a prominent player in the in vitro diagnostics sector, continues to make strides in enhancing pat…
Enhancing Diagnostic Clarity: QuidelOrtho's Commitment to Respiratory Illness Testing QuidelOrtho Corporation, a prominent player in the in vitro diagnostics field, continues to emphasize the signific…
QuidelOrtho Secures Strategic Refinancing to Propel Growth QuidelOrtho Corporation, a leader in in-vitro diagnostic technologies, undertakes significant refinancing to bolster its financial foundation…
QuidelOrtho Elevates Strategic Leadership with New Executive Appointment QuidelOrtho Corporation, a prominent player in the in vitro diagnostics industry, strengthens its leadership team with the appo…
QuidelOrtho Strengthens Leadership with Strategic Appointment QuidelOrtho Corporation, a prominent entity in the in vitro diagnostics industry, recently announces the appointment of Erich Wolff as Exe…
QuidelOrtho Strengthens Leadership with New Executive Appointment QuidelOrtho Corporation, a prominent figure in the in vitro diagnostics sector, enhances its strategic leadership with the appointment…
QuidelOrtho Enhances Diagnostic Solutions Amidst Market Optimism QuidelOrtho, a leading player in the diagnostics industry, is making significant strides in expanding its portfolio of rapid testing so…
QuidelOrtho: Pioneering Diagnostic Testing Solutions in a Growing Market QuidelOrtho is at the forefront of the diagnostic testing industry, leveraging innovative technologies to deliver accurate and…
QuidelOrtho Navigates Challenges Amid Decreased Diagnostic Revenues QuidelOrtho Corporation, a prominent player in the in-vitro diagnostic technology sector, faces significant challenges as it reports…
QuidelOrtho Showcases Innovative Diagnostic Solutions at Upcoming J.P. Morgan Healthcare Conference QuidelOrtho Corporation, a prominent player in the global in-vitro diagnostic technologies sector, i…
Innovating Diagnostics: QuidelOrtho's Commitment to Healthcare Transformation QuidelOrtho Corporation, a prominent leader in in-vitro diagnostic technologies, announces its participation in the upcomi…
QuidelOrtho Fortifies Its Board with Strategic Appointments QuidelOrtho Corporation, a prominent player in the in vitro diagnostic technology sector, announces the strategic appointments of John R. Ch…
QuidelOrtho's Strategic Shift: Navigating Shareholder Changes QuidelOrtho Corporation, a prominent player in the in vitro diagnostics industry, announces a secondary offering of 8,260,183 shares of it…
QuidelOrtho's Secondary Offering Marks Significant Shift in Shareholder Dynamics QuidelOrtho Corporation, a prominent player in the in vitro diagnostics sector, announces a secondary offering of 8,260…